LU Lin


Born in 1966. National of China. Professor/Director, National Institute on Drug Dependence, Peking University; Professor/Director, Peking University Sixth Hospital/Institute of Mental Health; Professor/Director, National Clinical Research Center for Mental Disorder, China; Chairman, Expert Committee on Drug Abuse Prevention and Control, National Narcotics Control Committee; Chairman, Expert Committee on Psychiatry and Mental Health of National Health Commission, China; Vice President, International Chinese Psychiatric Association; Vice President, Asia Research Association on Drug Abuse; Committee Member, WHO Expert Committee on Drug Dependence; Associate Editor, Drug and Alcohol Dependence; Associate Editor, The American Journal on Addictions.

M.D. and Ph.D. in Psychiatry, West China University of Medical Sciences, China.

Previously held positions as Research Scientist, National Institute on Drug Abuse, NIH, USA (2003-2006); Postdoctoral Fellow, National Institute on Drug Abuse, NIH, USA (2001-2003).

Author of and contributor to numerous publications including: 2019-nCoV epidemic: address mental health care to empower society, Lancet (2020), 395(10224), e37-e38; Control of fentanyl-related substances in China. Lancet Psychiatry (2019), 6(7), e15; Effect of Selective Inhibition of reactivated nicotine-associated memories with propranolol on nicotine craving, JAMA Psychiatry (2017), 74(3), 224-232; Selective Inhibition of Amygdala Neuronal ensembles encoding nicotine-associated memories inhibits nicotine preference and relapse, Biol Psychiatry 2017, 82(11), 781-793; A novel UCS memory retrieval-extinction procedure to inhibit relapse to drug seeking, Nat Commun. (2015), 6, 7675; A memory retrieval-extinction procedure to prevent drug craving and relapse, Science (2012), 336(6078), 241-245.

Honors include: National Innovation Award (2020); Academician of Chinese Academy of Science Members (2017); Chinese Medical Science and Technology Award (2015 and 2008); Natural Science Award of the Ministry of Education (2013 and 2008); National Natural Science Award (2002).

Member of the International Narcotics Control Board (since 2022) [1]. Member of the Standing Committee on Estimates (2022 and 2024). Member of the Committee on Finance and Administration (2023).

[1] Elected by the Economic and Social Council on 20 April 2021.


©1995-2024 International Narcotics Control Board